Drug Target Development and Validation for Antimicrobial-Resistant Pathogens (R21/R33)
ArchivedNational Institutes of Health
Description
To support basic to translational research focused on characterization and validation of novel antimicrobial targets for development of new therapeutic interventions against select antimicrobial-resistant bacterial pathogens.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
Key dates & funding
- PostedMar 26, 2013
- ClosesJul 18, 2013
- Program funding$3,500,000
- CFDA93.855, 93.856
Categories
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro